Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimaging biomarkers to predict CBT versus SSRI outcome in obsessive-compulsive disorder
NL-OMON45849Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2016
- Countries
- 1
01
Overview
Randomised, open-label trial in obsessive compulsive disorder (OCD) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Classifier accuracy for treatment response prediction, Difference in responder proportions between randomized and biomarker-allocated cohorts and 5 more. Started Nov 2016; status: terminated.
02
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NL-OMON45849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45849.